The understanding of small cell lung cancer (SCLC) biology has increased dramatically
in recent years, but the processes that allow SCLC to progress rapidly remain poorly
understood. Here, we advocate the integration of rapid autopsies and preclinical models
into SCLC research as a comprehensive strategy with the potential to revolutionize
current treatment paradigms.